Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427804 · ClinicalTrials.gov registry record · NA
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
A NA study, sponsored by Atlanta VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00427804 is a NA study that has completed, run by Atlanta VA Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT00427804, a NA study, has completed, sponsored by Atlanta VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study is a pilot study to determine whether patients with TNFα excess have decreased calcium absorption in response to calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D) compared to normal controls. This initial pilot study is being done to determine if it is feasible to conduct a study where TNFα could be blocked (e.g., by anti-TNFα therapy such as Enbrel® or Remicade®) to improve vitamin D dependant calcium absorption and thus bone health.
Interventions
- DRUG calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00427804
The ClinicalTrials.gov registry entry for NCT00427804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlanta VA Medical Center, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which calcitriol is the first listed.
NCT00427804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00427804 about?
NCT00427804 is a clinical study titled "Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption". This study is a pilot study to determine whether patients with TNFα excess have decreased calcium absorption in response to calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D) compared to normal controls. This initial pilot study is being done to determine if it is feasible to conduct...
What is the current status of trial NCT00427804?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2007-01. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00427804?
The interventions under investigation include: calcitriol (DRUG).
Who is sponsoring clinical trial NCT00427804?
This trial is sponsored by Atlanta VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.